Unexplained Infertility: What It Really Means and What to Do Next

Receiving a diagnosis of "unexplained infertility" can feel like a deeply unsatisfying answer. You've gone through testing, often invasive and stressful testing, and emerged with no clear reason why conception hasn't happened. The diagnosis can feel like being told "we don't know" — which, in some ways, it is.

But unexplained infertility is more nuanced than a simple absence of diagnosis. It affects approximately 10–30% of couples presenting to fertility clinics, making it one of the most common categories of infertility. Understanding what it means — and crucially, what it doesn't mean — is the first step to finding a path forward.

What Is Unexplained Infertility? Defining the Diagnosis

Unexplained infertility (UI) is defined as the failure to conceive after 12 months of regular, unprotected intercourse (or 6 months for women over 35) when standard fertility investigations have returned normal results.

"Standard investigations" typically include:

• Semen analysis (concentration, motility, morphology)
• Ovarian reserve assessment (AMH, antral follicle count, day 2-3 FSH/oestradiol)
• Confirmation of ovulation (serum progesterone on day 21, or ultrasound monitoring)
• Assessment of tubal patency (hysterosalpingography or laparoscopy/dye)
• Uterine assessment (usually by ultrasound or hysteroscopy)

The key word is standard. Current diagnostic tests do not capture every dimension of reproductive function. When these standard tests return normal results, the underlying cause hasn't necessarily been eliminated — it may simply lie beyond the resolution of current routine diagnostics.

What Standard Tests Miss: The Hidden Causes

Research over the past decade has identified numerous factors that can impair fertility without appearing on a standard semen analysis or hormonal panel:

Subtle Egg Quality Issues: Standard investigations confirm ovulation occurs, but they do not assess the quality of the egg released. Egg quality — determined by chromosomal integrity, mitochondrial function, and cytoplasmic maturation — is not measurable by routine bloodwork. Poor egg quality (often related to age, oxidative stress, or endometrial environment) can result in fertilisation failure or very early embryo arrest before implantation.

Sperm DNA Fragmentation: A conventional semen analysis is reassuringly normal for many men in UI couples — but it doesn't assess sperm DNA integrity. Studies show that 15–25% of men with normal semen analyses have elevated DNA fragmentation indices (DFI >25%). High DFI impairs fertilisation, reduces blastocyst formation, and significantly increases miscarriage risk. DNA fragmentation testing is not routinely offered at all centres.

Endometrial Receptivity: Implantation requires a precisely receptive endometrium — expressing the right molecular markers during the "window of implantation" (WOI), typically days 19–21 of a 28-day cycle. Research suggests some women have a displaced WOI, where the endometrium is receptive earlier or later than expected. Endometrial Receptivity Array (ERA) testing can identify this displacement and guide the timing of embryo transfer.

Subclinical Endometriosis: Endometriosis is found at laparoscopy in 20–30% of women with unexplained infertility who were previously told their tubes were clear. Minimal and mild endometriosis (Stage I–II) can impair oocyte quality, fertilisation, and implantation through inflammatory mechanisms without causing tubal blockage detectable by HSG.

Immune Factors: Emerging research implicates uterine natural killer (uNK) cell abnormalities and antiphospholipid antibody syndrome in a subset of UI cases. Elevated uNK cell activity may cause failure of implantation or very early pregnancy loss before clinical recognition.

Functional Tubal Dysfunction: Tubes that are "open" on a hysterosalpingogram may still have impaired peristalsis or ciliary function that prevents efficient transport of the oocyte or embryo. This is very difficult to assess by current standard tests.

Microbiome Dysbiosis: The uterine microbiome is a new frontier. Studies suggest that a uterine environment dominated by non-Lactobacillus bacteria is associated with lower implantation and pregnancy rates. The vaginal and uterine microbiome can be assessed by EMMA (Endometrial Microbiome Metagenomic Analysis) testing, though this is still specialist and not widely available.

The Psychological Impact of Unexplained Infertility

While this article is primarily clinical, it would be incomplete without acknowledging the psychological dimension. Several studies have found that women with unexplained infertility experience higher levels of anxiety, depression, and helplessness than women with a diagnosed cause — perhaps because there is no identifiable target for intervention.

The lack of explanation can also affect relationship dynamics. Partners sometimes unconsciously wonder if the other is "more responsible" for the fertility challenge. Counselling — ideally with a fertility-specialist psychologist — is not just helpful but genuinely important.

It's also worth noting that stress itself, through cortisol-mediated suppression of reproductive hormones and reduced uterine blood flow, can impair fertility. While stress is not a sufficient explanation for unexplained infertility, addressing it is a legitimate part of the treatment approach.

Evidence-Based Treatment Options for Unexplained Infertility

Treatment decisions in UI should be guided by age, duration of infertility, and patient preference. A useful framework is to move from less to more invasive interventions:

Expectant Management (Watchful Waiting): For younger women (<35) with a shorter duration of infertility (<2 years), expectant management — optimising health while trying naturally — is a legitimate first approach. A 2019 prospective study found that 30–40% of UI couples in this demographic conceived within 2 years without treatment.

Optimising Natural Conception: Even without a diagnosis, there is substantial room for intervention. Timing intercourse precisely to the LH surge (using digital OPKs), optimising nutrition, reducing oxidative stress, managing weight, and using a fertility-optimised lubricant can all meaningfully improve natural conception chances.

Ovulation Stimulation with Timed Intercourse (OS-TI): Using letrozole or clomiphene to produce 1–2 mature follicles, combined with timed intercourse, is a common step-up from natural trying. The evidence base is modest — a large RCT (the Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation, AMIGOS trial) found no significant benefit of OS-TI over natural trying in an unselected UI population. However, some clinicians argue it may benefit a subgroup, particularly those with subtle ovulatory dysfunction.

Intrauterine Insemination (IUI): IUI involves placing washed, concentrated sperm directly into the uterine cavity around ovulation. It bypasses cervical mucus, increases sperm numbers at the site of fertilisation, and can be combined with mild ovarian stimulation. Success rates per cycle in UI are modest (10–15%), but cumulative rates over 3–6 cycles reach 30–50%. IUI is generally recommended before proceeding to IVF, as it is substantially less costly and invasive.

In Vitro Fertilisation (IVF): IVF achieves fertilisation in a controlled laboratory environment, bypassing many of the potential barriers in UI. It also provides diagnostic information — if fertilisation fails or embryo quality is poor in the laboratory, this narrows the differential. Success rates depend strongly on age: approximately 35–40% per cycle under 35, declining to 10–15% for women over 42. IVF does not, however, improve egg or sperm quality — it works around certain barriers but doesn't address underlying causes.

Add-On Investigations and Treatments: For couples who have failed multiple IUI or IVF cycles, additional investigation with ERA testing, sperm DNA fragmentation testing, endometrial microbiome analysis, and uNK cell testing may identify treatable factors. Targeted interventions based on these findings (adjusted embryo transfer timing, antioxidant therapy for high DFI, antibiotics for endometrial dysbiosis, prednisolone for elevated uNK cells) are increasingly offered in specialist centres, though the evidence base for each is still evolving.

Natural Interventions with Evidence in Unexplained Infertility

While lifestyle modifications are beneficial in all fertility contexts, several have specific relevance in UI:

Antioxidant Supplementation: Given the potential roles of oxidative stress in egg quality, sperm DNA integrity, and endometrial function, comprehensive antioxidant supplementation is one of the most evidence-aligned interventions. For women: folate, CoQ10, vitamin D, vitamin E, and selenium. For men: vitamin C, vitamin E, CoQ10, zinc, selenium, L-carnitine, and omega-3. The MOXI trial (2020) found that antioxidant treatment for men in UI couples improved fertilisation rates and pregnancy outcomes.

Body Weight Optimisation: Both obesity and underweight are associated with impaired fertility. Even in UI, where no hormonal abnormality is detected, maintaining a BMI of 18.5–24.9 is associated with better natural and treatment outcomes. Visceral adiposity promotes systemic inflammation that can impair implantation without causing obvious hormonal disruption.

Reducing Environmental Toxin Exposure: Endocrine-disrupting chemicals (BPA, phthalates, parabens) can impair both oocyte and sperm quality through mechanisms that aren't captured by standard testing. Reducing plastic food container use, choosing fragrance-free personal care products, and eating organic where possible reduces this exposure.

Acupuncture: Acupuncture has the most consistent evidence base among complementary therapies in fertility, with several RCTs finding improvements in uterine blood flow, stress hormone levels, and IVF outcomes. While not a proven treatment for UI specifically, the benefit:risk ratio is favourable for women undergoing treatment cycles.

Fertility Lubricants and Unexplained Infertility

One often-overlooked factor in unexplained infertility is the lubricant used during intercourse. Many commonly used lubricants — including saliva, olive oil, and most commercial lubricants — are harmful to sperm, reducing motility by 60–100% within 30 minutes of contact. For couples where even small optimisations may make a difference, switching to a sperm-safe, pH-appropriate lubricant is a simple, cost-free change with potential benefit.

The Role of Advanced Diagnostics: Should You Push for More?

Given the limitations of standard testing, some couples wonder whether they should advocate for more advanced investigations before proceeding to treatment. In general:

• Sperm DNA fragmentation testing is reasonable, especially if there has been recurrent early miscarriage or if IUI/IVF cycles have produced poor-quality embryos. It's available at many fertility clinics in Australia and is increasingly included in standard protocols.
• ERA testing is most relevant for women who have had 2 or more failed IVF cycles with good-quality embryos.
• Laparoscopy to exclude endometriosis may be considered for women with pelvic pain, dysmenorrhoea, or a clinical suspicion of endometriosis who have not responded to initial treatment.
• Immune testing remains controversial and is not standard care; it is most relevant in the context of recurrent implantation failure.

Frequently Asked Questions About Unexplained Infertility

Q: Does unexplained infertility mean we can never have children?
A: Absolutely not. The prognosis for UI is generally positive. Many couples conceive naturally over time, and those who need treatment have excellent cumulative pregnancy rates with IUI and IVF. The absence of a diagnosed cause does not equate to untreatable infertility.

Q: Should we go straight to IVF with unexplained infertility?
A: Not necessarily. IVF is the most effective per-cycle treatment, but for most couples — especially younger women — a step-up approach through IUI first is appropriate, given the significant difference in cost, invasiveness, and multiple pregnancy risk. Age is a critical factor: for women over 38, moving more quickly to IVF is usually advisable.

Q: Is it worth trying for longer before seeking treatment?
A: Depends on age and circumstances. Under 35 with a short infertility duration, watching and optimising is reasonable for a further 3–6 months. Over 35, or with any additional risk factors, seeking specialist input sooner is better. Time is one of the most precious resources in fertility — don't wait unnecessarily.

Q: Can stress cause unexplained infertility?
A: Stress probably contributes in some cases — it affects the hypothalamic-pituitary-ovarian axis, uterine blood flow, and sperm production — but it is unlikely to be the sole cause. Framing infertility as "just stress" is an oversimplification that can be hurtful and dismissive. Manage stress for overall wellbeing, but don't treat it as the explanation.

Q: How many IUI cycles should we try before moving to IVF?
A: Most guidelines suggest 3–6 IUI cycles before progressing to IVF. Age-adjusted guidance: under 35, up to 6 cycles is reasonable; over 38, 3 cycles before reassessing. Individual factors — partner sperm quality, stimulation response, cost — all inform this decision.

Q: Should the male partner be retested if initial semen analysis was normal?
A: Yes, particularly if initial testing was done some time ago, if lifestyle factors have changed, or if there have been subsequent miscarriages. Requesting sperm DNA fragmentation testing in addition to repeat semen analysis is worthwhile in the context of unexplained infertility.

Q: Is there anything specific about Australian fertility healthcare I should know?
A: Australia has excellent fertility services. IVF cycles are partially rebated under Medicare (for eligible patients), and a referral from your GP to a fertility specialist (reproductive endocrinologist) is a good starting point. NHMRC-endorsed guidelines are followed by Australian fertility clinics, and the live birth rates reported to ANZARD (the Australian and New Zealand Assisted Reproduction Database) are internationally competitive.

Q: What role does the thyroid play in unexplained infertility?
A: Thyroid function is usually checked in standard fertility workup, but the threshold matters. Subclinical hypothyroidism (TSH 2.5–4.5 mIU/L) — often missed as "within range" — is increasingly associated with impaired implantation and early miscarriage. Many reproductive endocrinologists target TSH <2.5 mIU/L before and during early pregnancy. If yours hasn't been tested recently, ask for a full thyroid panel.